PANews reported on October 7 that according to Globenewswire, MAIA Biotechnology, listed on NYSE American under the New York Stock Exchange, announced the official launch of its crypto treasury strategy. At the same time, its board of directors has approved investing 90% of the company's liquid assets in leading cryptocurrencies. The initial investment will purchase BTC, ETH and USDC. It is reported that the company will also establish a digital asset advisory committee to provide support for related purchase transactions.
MAIA Biotechnology, a US-listed company, launches a crypto-treasury strategy
Share to:
Follow PANews official accounts, navigate bull and bear markets together
Recommended Reading
PA一线1 hour agoPA一线2 hour agoPA一线3 hour ago
x402 Protocol: A New Standard for Agent Payments
The x402 protocol aims to solve the core payment dilemma in the AI Agent economy through blockchain technology, providing an autonomous and low-cost on-chain payment solution for high-frequency, small-amount transactions between AI Agents.
Pioneer's View: Crypto Celebrity Interviews
Exclusive interviews with crypto celebrities, sharing unique observations and insights
PAData: Web3 in Data
Data analysis and visual communication of industry hot spots help users understand the meaning and opportunities behind each data.
A complete review of the 1011 encryption storm
An in-depth review of the epic liquidation events of October 11: from the Trump tariff black swan event to high-leverage margin calls, stablecoin depegging, and market maker liquidity depletion.
ETHShanghai 2025: Discussing the Future of Ethereum
The theme of this conference is "Expanding Ethereum, Shaping an Open Future". It is co-hosted by the Chinese-speaking blockchain builder community ETHPanda, Wanxiang Blockchain Labs, PANews and TinTinLand.
AI Agent: The Journey to Web3 Intelligence
The AI Agen innovation wave is sweeping the world. How will it take root in Web3? Let’s embark on this intelligent journey together